Contrast agent firm E-Z-EM of Westbury, NY, has appointed Judith Meritz as vice president of regulatory affairs. Meritz, who was previously director of regulatory affairs and regulatory counsel for healthcare supply firm Henry Schein, will cover E-Z-EM's diagnostic products division, and will also handle contrast media products, related medical devices, and immunoassay tests.
By AuntMinnie.com staff writersMarch 20, 2001
Related Reading
E-Z-EM revenue, earnings slip, January 17, 2001
E-Z-EM inks European deal with Nycomed-Amersham, December 18, 2000
Copyright © 2001 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
